Glucose control in the ICU: Is there a time for more ambitious targets again?

Journal of Diabetes Science and Technology

Volumn 8, Issue 4, 2014, Pages 652-657

  Haluzik, Martin ^a   Mraz, Milos ^a   Kopecky, Petr ^a   Lips, Michal ^a   Svacina, Stepan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Continuous glucose monitoring; Critically ill patients; Glucose control; Hypoglycemia; Intensive care unit

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ALGORITHM; CRITICAL ILLNESS; GLUCOSE BLOOD LEVEL; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; PROCEDURES;

ALGORITHMS; BLOOD GLUCOSE; CRITICAL ILLNESS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE; INTENSIVE CARE UNITS;

EID: 84905910199     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814533847     Document Type: Article

References (57)

1. Vanhorebeek I, Langouche L, Van den Berghe G. Modulating the endocrine response in sepsis: insulin and blood glucose control. Novartis Found Symp. 2007;280:204-215; discussion 15-22.
2. Van den Berghe G. Endocrinology in intensive care medicine: new insights and therapeutic consequences. Verh K Acad Geneeskd Belg. 2002;64:167-187; discussion 87-88.
3. Coursin DB, Connery LE, Ketzler JT. Perioperative diabetic and hyperglycemic management issues. Crit Care Med. 2004;32:S116-S125.
4. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res. 2001;15:533-551.
5. Bagshaw SM, Egi M, George C, et al. Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med. 2009;37:463-470.
6. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36:3008-3013.
7. Weekers F, Giulietti AP, Michalaki M, et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology. 2003;144:5329-5338.
8. Schetz M, Vanhorebeek I, Wouters PJ, et al. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol. 2008;19:571-578.
9. Sanap MN, Worthley LI. Neurologic complications of critical illness: part II. Polyneuropathies and myopathies. Crit Care Resusc. 2002;4:133-140.
10. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract. 2004;10 Suppl 2:46-52.
11. Blondet JJ, Beilman GJ. Glycemic control and prevention of perioperative infection. Curr Opin Crit Care. 2007;13:421-427.
12. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290:2041-2047.
13. Krinsley JS. Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital. Semin Thorac Cardiovasc Surg. 2006;18:317-325.
14. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. New Engl J Med. 2001;345:1359-1367.
15. Soop M, Nygren J, Thorell A, Ljungqvist O. Stress-induced insulin resistance: recent developments. Curr Opin Clin Nutr Metab Care. 2007;10:181-186.
16. Zimmerman CR, Mlynarek ME, Jordan JA, et al. An insulin infusion protocol in critically ill cardiothoracic surgery patients. Ann Pharmacother. 2004;38:1123-1129.
17. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738-1748.
18. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. New Engl J Med. 2009;360:1283-1297.
19. Devos P, Preiser JC. Is it time for implementation of tight glycaemia control by intensive insulin therapy in every ICU? Crit Care. 2006;10:130.
20. De Block C, Manuel-y-Keenoy B, Rogiers P, et al. Glucose control and use of continuous glucose monitoring in the intensive care unit: a critical review. Curr Diabetes Rev. 2008;4:234-244.
21. Ichai C, Preiser JC, Societe Francaise dA-R, et al. International recommendations for glucose control in adult non diabetic critically ill patients. Crit Care. 2010;14:R166.
22. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180:821-827.
23. Blaha J, Kopecky P, Matias M, et al. Comparison of three protocols for tight glycemic control in cardiac surgery patients. Diabetes Care. 2009;32:757-761.
24. Andreelli F, Jacquier D, Troy S. Molecular aspects of insulin therapy in critically ill patients. Curr Opin Clin Nutr Metab Care. 2006;9:124-130.
25. Langley J, Adams G. Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review. Diabetes Metab Res Rev. 2007;23:184-192.
26. Van den Berghe G. Insulin therapy for the critically ill patient. Clin Cornerstone. 2003;5:56-63.
27. Kanji S, Singh A, Tierney M, et al. Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med. 2004;30:804-810.
28. Hovorka R, Kremen J, Blaha J, et al. Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. J Clin Endocrinol Metab. 2007;92:2960-2964.
29. Hovorka R, Chassin LJ, Wilinska ME, et al. Closing the loop: the adicol experience. Diabetes Technol Ther. 2004;6:307-318.
30. Plank J, Blaha J, Cordingley J, et al. Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients: response to Ligtenberg, et al. Diabetes Care. 2006;29:1987-1988.
31. Meijering S, Corstjens AM, Tulleken JE, et al. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care. 2006;10:R19.
32. Preiser JC, Devos P, Van den Berghe G. Tight control of glycaemia in critically ill patients. Curr Opin Clin Nutr Metab Care. 2002;5:533-537.
33. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151-3159.
34. Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care. 2006;15:370-377.
35. De Block C, Manuel-y-Keenoy B, Van Gaal L. A review of current evidence with continuous glucose monitoring in patients with diabetes. J Diabetes Sci Technol. 2008;2:718-727.
36. Basu A, Dube S, Slama M, et al. Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes. 2013;62:4083-4087.
37. Kao LS, Meeks D, Moyer VA, Lally KP. Peri-operative glycaemic control regimens for preventing surgical site infections in adults. Cochrane Database Syst Rev. 2009:CD006806.
38. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004:1497-1502.
39. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146:233-243.
40. Hua J, Chen G, Li H, et al. Intensive intraoperative insulin therapy versus conventional insulin therapy during cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth. 2012;26:829-834.
41. Kopecky P, Mraz M, Lips M, et al. Perioperative initiation of tight glucose control reduces postoperative adverse events in elective cardiac surgery patients: a randomized controlled trial. Diabetes. 2013;62:A81.
42. De Block C, Manuel YKB, Van Gaal L, Rogiers P. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care. 2006;29:1750-1756.
43. Ellmerer M, Haluzik M, Blaha J, et al. Clinical evaluation of alternative-site glucose measurements in patients after major cardiac surgery. Diabetes Care. 2006;29:1275-1281.
44. Finfer S, Wernerman J, Preiser JC, et al. Clinical review: consensus recommendations on measurement of blood glucose and reporting glycemic control in critically ill adults. Crit Care. 2013;17:229.
45. Kopecky P, Mraz M, Blaha J, et al. The use of continuous glucose monitoring combined with computer-based eMPC algorithm for tight glucose control in cardiosurgical ICU. BioMed Res Int. 2013;2013:186439.
46. Leelarathna L, English SW, Thabit H, et al. Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial. Crit Care. 2013;17:R159.
47. Siegelaar SE, Barwari T, Hermanides J, et al. Microcirculation and its relation to continuous subcutaneous glucose sensor accuracy in cardiac surgery patients in the intensive care unit. J Thorac Cardiovasc Surg. 2013;146:1283-1289.
48. Leelarathna L, English SW, Thabit H, et al. Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrations. Diabetes Technol Ther. 2014;16:97-101.
49. Blixt C, Rooyackers O, Isaksson B, Wernerman J. Continuous on-line glucose measurement by microdialysis in a central vein. A pilot study. Crit Care. 2013;17:R87.
50. Zander R, Boldt J, Engelmann L, et al. [The design of the VISEP trial. Critical appraisal]. Anaesthesist. 2007;56:71-77.
51. Van den Berghe G. Intensive insulin therapy in the ICU-reconciling the evidence. Nature Rev Endocrinol. 2012;8: 374-378.
52. Lonborg J, Vejlstrup N, Kelbaek H, et al. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J. 2012;33:1491-9.
53. Galiatsatos P, Gibson BR, Rabiee A, et al. The glucoregulatory benefits of glucagon-like Peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study. Crit Care Med. 2014;42:638-645.
54. Ahren B. GLP-1 and extra-islet effects. Horm Metab Res. 2004;36:842-845.
55. Harkavyi A, Whitton PS. Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection. Brit J Pharmacol. 2010;159:495-501.
56. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. New Engl J Med. 2008;358:2545-2559.
57. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. New Engl J Med. 2009;360:129-139.